SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 4/25/17 Dupont E I De Nemours & Co 10-Q 3/31/17 81:9.5M |
Document/Exhibit Description Pages Size 1: 10-Q Quarterly Report HTML 527K 2: EX-10.16 Material Contract HTML 114K 3: EX-10.23 Material Contract HTML 140K 4: EX-10.25 Material Contract HTML 1.17M 5: EX-12 Statement re: Computation of Ratios HTML 32K 6: EX-31.1 Certification -- §302 - SOA'02 HTML 32K 7: EX-31.2 Certification -- §302 - SOA'02 HTML 32K 8: EX-32.1 Certification -- §906 - SOA'02 HTML 26K 9: EX-32.2 Certification -- §906 - SOA'02 HTML 26K 16: R1 Document and Entity Information HTML 43K 17: R2 Consolidated Income Statements HTML 91K 18: R3 Consolidated Statements of Comprehensive Income HTML 52K 19: R4 Condensed Consolidated Balance Sheets HTML 121K 20: R5 Condensed Consolidated Balance Sheets HTML 36K (Parenthetical) 21: R6 Condensed Consolidated Statements of Cash Flows HTML 103K 22: R7 Summary of Significant Accounting Policies HTML 47K 23: R8 Planned Merger with Dow Chemical Planned Merger HTML 38K with Dow Chemical 24: R9 Divestitures and Other Transactions HTML 38K 25: R10 Employee Separation / Asset Related Charges, Net HTML 65K 26: R11 Other Income, Net HTML 62K 27: R12 Provision for Income Taxes HTML 30K 28: R13 Earnings Per Share of Common Stock HTML 51K 29: R14 Inventories HTML 35K 30: R15 Other Intangible Assets HTML 79K 31: R16 Short-Term and Long-Term Borrowings HTML 31K 32: R17 Commitments and Contingent Liabilities HTML 83K 33: R18 Stockholders' Equity HTML 133K 34: R19 Financial Instruments HTML 142K 35: R20 Long-Term Employee Benefits HTML 58K 36: R21 Segment Information HTML 101K 37: R22 Summary of Significant Accounting Policies Summary HTML 47K of Significant Accounting Policies (Policies) 38: R23 Employee Separation / Asset Related Charges, Net HTML 61K (Tables) 39: R24 Other Income, Net (Tables) HTML 62K 40: R25 Earnings Per Share of Common Stock (Tables) HTML 52K 41: R26 Inventories (Tables) HTML 36K 42: R27 Other Intangible Assets (Tables) HTML 76K 43: R28 Commitments and Contingent Liabilities (Tables) HTML 52K 44: R29 Stockholders' Equity (Tables) HTML 130K 45: R30 Financial Instruments (Tables) HTML 129K 46: R31 Long-Term Employee Benefits (Tables) HTML 57K 47: R32 Segment Information (Tables) HTML 102K 48: R33 Summary of Significant Accounting Policies Summary HTML 33K of Significant Accounting Policies (Narrative) (Details) 49: R34 Planned Merger with Dow Chemical Planned Merger HTML 36K with Dow Chemical (Narrative) (Details) 50: R35 Divestitures and Other Transactions (Narrative) HTML 56K (Details) 51: R36 Employee Separation / Asset Related Charges, Net HTML 61K Employee Separation / Asset Related Charges, Net (2017 Restructuring Program schedule) (Details) 52: R37 Employee Separation / Asset Related Charges, Net HTML 36K Employee Separation / Asset Related Charges, Net (La Porte) (Narrative) (Details) 53: R38 Employee Separation / Asset Related Charges, Net HTML 66K Employee Separation / Asset Related Charges, Net (2016 Restructuring Program schedule )(Details) 54: R39 Other Income, Net (Schedule of Other Income) HTML 66K (Details) 55: R40 Other Income, Net (Schedule of Foreign Exchange HTML 36K Gain (Loss)) (Details) 56: R41 Provision for Income Taxes (Details) HTML 32K 57: R42 Earnings Per Share of Common Stock (Earnings Per HTML 48K Share of Common Stock Reconciliation) (Details) 58: R43 Earnings Per Share of Common Stock (Schedule of HTML 29K Average Number of Antidilutive Stock Options) (Details) 59: R44 Inventories (Details) HTML 37K 60: R45 Other Intangible Assets (Schedule of Other HTML 66K Intangible Assets) (Details) 61: R46 Other Intangible Assets (Narrative) (Details) HTML 44K 62: R47 Short-Term and Long-Term Borrowings (Details) HTML 57K 63: R48 Commitments and Contingent Liabilities HTML 55K (Guarantees) (Details) 64: R49 Commitments and Contingent Liabilities HTML 122K (Litigation) (Narrative) (Details) 65: R50 Commitments and Contingent Liabilities Commitments HTML 38K and Contingent Liabilities (Environmental) (Narrative) (Details) 66: R51 Stockholders' Equity Stockholder's Equity HTML 59K (Details) 67: R52 Stockholders' Equity Stockholder's Equity HTML 30K (Schedule of tax benefit (Expense) on Net Activity) (Details) (Details) 68: R53 Stockholders' Equity Stockholders' Equity HTML 68K (Reclassifications out of accumulated other Comprehensive Income / (Loss)) (Details) (Details) 69: R54 Financial Instruments Financial Insttruments HTML 51K (Schedule of Cash, Cash Equivalents and Marketable Securities) (Details) 70: R55 Financial Instruments (Debt) (Narrative) (Details) HTML 26K 71: R56 Financial Instruments (Notional Amounts of HTML 32K Derivatives) (Details) 72: R57 Financial Instruments (Effect of Cash Flows Hedges HTML 38K on Accumulated Other Comprehensive Income (Loss)) (Details) 73: R58 Financial Instruments (Schedule of the Fair Value HTML 52K of Derivative Instruments) (Details) 74: R59 Financial Instruments (Effect of Derivative HTML 52K Instruments) (Details) 75: R60 Long-Term Employee Benefits (Schedules of Net HTML 59K Periodic Benefit Cost) (Details) 76: R61 Segment Information (Schedule of Segment HTML 48K Information) (Details) 77: R62 Segment Information (Reconciliation to HTML 68K Consolidated Income Statements) (Details) 78: R63 Segment Information (Significant Pre-tax (charges) HTML 86K benefits not included in Segment Operating Earnings) (Details) 80: XML IDEA XML File -- Filing Summary XML 143K 79: EXCEL IDEA Workbook of Financial Reports XLSX 89K 10: EX-101.INS XBRL Instance -- dd-20170331 XML 2.43M 12: EX-101.CAL XBRL Calculations -- dd-20170331_cal XML 198K 13: EX-101.DEF XBRL Definitions -- dd-20170331_def XML 940K 14: EX-101.LAB XBRL Labels -- dd-20170331_lab XML 1.57M 15: EX-101.PRE XBRL Presentations -- dd-20170331_pre XML 1.03M 11: EX-101.SCH XBRL Schema -- dd-20170331 XSD 201K 81: ZIP XBRL Zipped Folder -- 0000030554-17-000016-xbrl Zip 251K
Exhibit |
1. | I have reviewed this report on Form 10-Q for the period ended March 31, 2017 of E. I. du Pont de Nemours and Company; |
2. | Based
on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The
registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c) | Evaluated the effectiveness of the
registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d) | Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected,
or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and |
5. | The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent function): |
a) | All
significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and |
b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. |
Date: | |
By: | /s/ Edward D. Breen |
Chair of the Board and | |
Chief
Executive Officer |
This ‘10-Q’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 4/25/17 | 8-K | ||
For Period end: | 3/31/17 | 8-K | ||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/11/21 Corteva, Inc. 10-K 12/31/20 196:32M |